데이터를 보충하는 중입니다. 잠시 후 페이지를 새로 고치면 최신 내용을 볼 수 있습니다
84371-65-3CC#C[C@]1(O)CCC2C3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C84371-65-3Pale Yellow Solid
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
개요Mifepristone is an orally-active progesterone and glucocorticoid receptor antagonist indicated for use as a post-coital contraceptive. In addition to being an abortifacient, mifepristone is reported to be effective in the treatment of ocular hypertension; its potential therapeutic effect in hormone-dependent tumors is currently under investigation.
역사Mifepristone (brand name: Mifeprex) is an abortion drug approved by the FDA in 2000 for the medical termination of pregnancy, up to 7 weeks of gestation, an extension extended to 10 weeks in 2016. A generic version of Mifeprex, mifepristone tablets (200 mg), was approved in 2019. The drug has been in use for 25 years. However, following a study by the Center for Ethics and Public Policy (EPPC) showing that nearly 11% of women using the drug experience serious adverse events, the FDA is reviewing the safety of mifepristone.
용도Mifepristone is a progesterone receptor antagonist with partial agonist activity. Abortifacient.
현재 필터 조건에 해당하는 반응 기록이 없습니다.
불러오는 중…